In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioForm targets $115m IPO (initial public offering) for product push:

This article was originally published in Clinica

Executive Summary

Plastic surgery specialist BioForm Medical has filed for an initial public offering that could boost funds by $115m. The firm is looking to finance the development of its Radiesse injectable dermal filler, which received FDA pre-market approvals in December 2006 for the treatment of facial lipoatrophy - facial fat loss - in patients with HIV and for cosmetic correction of wrinkles. The San Mateo, California-based company will also use a portion of the offering proceeds to gain US regulatory approval of its varicose vein treatment Aethoxysklerol (currently in Phase III clinical trials in the US) and BioGlue, a surgical adhesive for use in browplasty, which is in early-stage human trials. BioForm holds exclusive US distribution rights to Aethoxysklerol and exclusive US and Canadian distribution rights to BioGlue for medical aesthetic applications.

You may also be interested in...



Coronavirus Update: Moderna Hold Up, Sanofi and Regeneron's Kevzara Fails In Phase III

Delay to Moderna's Phase III plans adds to the biotech's rollercoaster ride, but its CEO insists it is still on track.

Device Week, 3 July 2020 – Asia Regulatory Update & International Medical Device School

This week's Device Week podcast covers recent regulatory developments in Asia in the wake of COVID-19, and how regulators are adjusting to working under the pandemic. Having published two updates from our regular Asian Medtech Associations Reg Networking discussions this week, Medtech Insight speaks to Asia Regulatory Professional Association founder Jack Wong on Asian regulatory themes and South Korea's hosting of the next International Medical Device School.

WHO’s Cooke To Take Lead At EMA

Currently serving at the WHO, Emer Cooke is set to return to the EMA later this year in the role of executive director. She will have to tackle challenges posed by Brexit, COVID-19 and recent agency restructuring.

Topics

UsernamePublicRestriction

Register

ID1131432

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel